By a News Reporter-Staff News Editor at Physics Week -- Current study results on Low Temperature Physics have been published. According to news originating from Genoa, Italy, by VerticalNews correspondents, research stated, "We describe here the first experimental realization of a heat interferometer, thermal counterpart of the well-known superconducting quantum interference device. These findings demonstrate, in the first place, the existence of phase-dependent heat transport in Josephson-based superconducting circuits and, in the second place, open the way to novel ways of mastering heat at the nanoscale."
Our news journalists obtained a quote from the research from National Research Council, "Combining the use of external magnetic fields for phase biasing and different Josephson junction architectures we show here that a number of heat interference patterns can be obtained. The experimental realization of these architectures, besides being relevant from a fundamental physics point of view, might find important technological application as building blocks of phase-coherent quantum thermal circuits."
According to the news editors, the research concluded: "In particular, the performance of two different heat rectifying devices is analyzed."
For more information on this research see: Coherent Caloritronics in Josephson-Based Nanocircuits. Journal of Low Temperature Physics, 2014;175(5-6):813-837. Journal of Low Temperature Physics can be contacted at: Springer, Plenum Publishers, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Low Temperature Physics - www.springerlink.com/content/0022-2291/)
The news correspondents report that additional information may be obtained from M.J. Martinez-Perez, CNR, SPIN, I-16146 Genoa, Italy. Additional authors for this research include P. Solinas and F. Giazotto.
Keywords for this news article include: Genoa, Italy, Europe, Low Temperature Physics
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC